{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:48:04Z","timestamp":1791823684002,"version":"4.3.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-026-02894-x","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:25:36Z","timestamp":1784229936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Breast cancer radiotherapy in patients with autoimmune or cancer-associated myositis: balancing oncological benefit and immune-mediated risk"],"prefix":"10.1186","volume":"21","author":[{"given":"Sara","family":"Falivene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Mercogliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cascone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Ferraioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Mottareale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Ravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Caso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"3","key":"2894_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.rdc.2020.05.006","volume":"46","author":"S Moghadam-Kia","year":"2020","unstructured":"Moghadam-Kia S, Oddis CV, Ascherman DP, Aggarwal R. Risk Factors and Cancer Screening in Myositis. Rheum Dis Clin North Am. 2020;46(3):565\u201376.","journal-title":"Rheum Dis Clin North Am"},{"key":"2894_CR2","doi-asserted-by":"publisher","first-page":"1503140","DOI":"10.3389\/fonc.2025.1503140","volume":"15","author":"S Liu","year":"2025","unstructured":"Liu S, Zhang Z, Yan S, Yang C, Wang B, Shen M, et al. Risk, risk factors, and screening of malignancies in dermatomyositis: current status and future perspectives. Front Oncol. 2025;15:1503140.","journal-title":"Front Oncol"},{"key":"2894_CR3","doi-asserted-by":"crossref","unstructured":"Patt YS, Ben-Shabat N, David P, Patt C, Sharif K, Elizur Y, et al. Malignancy risk and predictors in dermatomyositis and polymyositis: a large population-based study. Med (Kaunas). 2025;61(11).","DOI":"10.3390\/medicina61111932"},{"key":"2894_CR4","doi-asserted-by":"crossref","unstructured":"Leemans E, De Haes P, Lenaerts J, De Langhe E, Blockmans D, Vanderschueren S, et al. Association between anti-synthetase syndrome and malignancy: a systematic review and meta-analysis. Rheumatology (Oxford). 2026.","DOI":"10.1093\/rheumatology\/keag110"},{"issue":"8","key":"2894_CR5","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s10067-016-3296-8","volume":"35","author":"YF Fang","year":"2016","unstructured":"Fang YF, Wu YJ, Kuo CF, Luo SF, Yu KH. Malignancy in dermatomyositis and polymyositis: analysis of 192 patients. Clin Rheumatol. 2016;35(8):1977\u201384.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"2894_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00403-020-02127-5","volume":"313","author":"R Tripathi","year":"2021","unstructured":"Tripathi R, Fernandez AP. Characteristics of hospitalized dermatomyositis patients with underlying malignancy: a nationally representative retrospective cohort study. Arch Dermatol Res. 2021;313(6):473\u201382.","journal-title":"Arch Dermatol Res"},{"key":"2894_CR7","doi-asserted-by":"publisher","first-page":"152283","DOI":"10.1016\/j.semarthrit.2023.152283","volume":"64","author":"A Allenzara","year":"2024","unstructured":"Allenzara A, Sadeghi N, Alvarez C, Maczuga S, Helm M, Olsen N, et al. Obesity is an independent risk factor for cancer development following diagnosis of dermatomyositis. Semin Arthritis Rheum. 2024;64:152283.","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"2894_CR8","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1007\/s10067-019-04782-0","volume":"39","author":"YK Sung","year":"2020","unstructured":"Sung YK, Jung SY, Kim H, Choi S, Im SG, Cha EJ, et al. Temporal relationship between idiopathic inflammatory myopathies and malignancies and its mortality: a nationwide population-based study. Clin Rheumatol. 2020;39(11):3409\u201316.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"2894_CR9","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1038\/s41598-021-83729-5","volume":"11","author":"JL Hsu","year":"2021","unstructured":"Hsu JL, Liao MF, Chu CC, Kuo HC, Lyu RK, Chang HS, et al. Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan. Sci Rep. 2021;11(1):4545.","journal-title":"Sci Rep"},{"issue":"34","key":"2894_CR10","doi-asserted-by":"publisher","first-page":"e21733","DOI":"10.1097\/MD.0000000000021733","volume":"99","author":"L Chang","year":"2020","unstructured":"Chang L, Zhang L, Jia H, Nie Z. Malignancy in dermatomyositis: A retrospective paired case-control study of 202 patients from Central China. Med (Baltim). 2020;99(34):e21733.","journal-title":"Med (Baltim)"},{"issue":"4","key":"2894_CR11","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/art.42311","volume":"75","author":"CA Mecoli","year":"2023","unstructured":"Mecoli CA, Igusa T, Chen M, Wang X, Albayda J, Paik JJ, et al. Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General Population. Arthritis Rheumatol. 2023;75(4):620\u20139.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"2894_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.abd.2023.01.007","volume":"99","author":"F Recul\u00e9","year":"2024","unstructured":"Recul\u00e9 F, Benedetto J, Silva-Hirschberg C, Cabrera R, Castro A. Bullous dermatomyositis with anti-NPX2 antibodies, associated with breast cancer. Bras Dermatol. 2024;99(2):305\u20137.","journal-title":"Bras Dermatol"},{"issue":"12","key":"2894_CR13","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1007\/s10067-023-06751-0","volume":"42","author":"A Manwatkar","year":"2023","unstructured":"Manwatkar A, Padiyar S, Nair A, Jha A, Kumar S, Yadav B, et al. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population. Clin Rheumatol. 2023;42(12):3289\u201397.","journal-title":"Clin Rheumatol"},{"issue":"12","key":"2894_CR14","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1111\/1346-8138.17426","volume":"51","author":"KY Tang","year":"2024","unstructured":"Tang KY, Zhang HL, Zhang XY, Jin HZ. Clinical and laboratory features between anti-TIF1\u03b3 dermatomyositis with and without malignancy: 37 case series and a review. J Dermatol. 2024;51(12):1646\u201357.","journal-title":"J Dermatol"},{"issue":"1","key":"2894_CR15","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1186\/s12885-016-2715-1","volume":"16","author":"O Kube\u010dek","year":"2016","unstructured":"Kube\u010dek O, Soukup T, Paul\u00edk A, Kopeck\u00fd J. Dermatomyositis with anti-TIF-1\u03b3 antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report. BMC Cancer. 2016;16(1):684.","journal-title":"BMC Cancer"},{"issue":"7","key":"2894_CR16","first-page":"1008","volume":"22","author":"WY Wang","year":"2024","unstructured":"Wang WY, Lee CY, Hu SC. Anti-TIF1-\u03b3-associated dermatomyositis associated with recurrent metastatic triple-negative breast cancer: Dramatic clinical response to sacituzumab govitecan. J Dtsch Dermatol Ges. 2024;22(7):1008\u201311.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"20","key":"2894_CR17","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.2169\/internalmedicine.0569-22","volume":"62","author":"H Akagi","year":"2023","unstructured":"Akagi H, Wada T. A Case in Which Breast Cancer Developed at the Same Time As Dermatomyositis, and the Onset of New Cancer Was Able to Be Predicted by the Exacerbating Skin Symptoms and Parallel Increase in the Anti-TIF1-\u03b3 Antibody Levels. Intern Med. 2023;62(20):3057\u201362.","journal-title":"Intern Med"},{"key":"2894_CR18","doi-asserted-by":"publisher","first-page":"1636581","DOI":"10.3389\/fimmu.2025.1636581","volume":"16","author":"H Han","year":"2025","unstructured":"Han H, Semenov M, Li C, Zhang Y, Lin T, Zheng P, et al. Case Report: Possible association between dermatomyositis and Trastuzumab Deruxtecan therapy of triple-negative breast cancer patient. Front Immunol. 2025;16:1636581.","journal-title":"Front Immunol"},{"issue":"1","key":"2894_CR19","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s12672-025-03172-0","volume":"16","author":"RR Colciago","year":"2025","unstructured":"Colciago RR, Presti D, Giandini C, Rocca E, Carnevale MG, Cavallo A, et al. Real world feasibility of combining pembrolizumab with radiotherapy in early triple negative breast cancer. Discov Oncol. 2025;16(1):1633.","journal-title":"Discov Oncol"},{"issue":"11","key":"2894_CR20","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.pmrj.2011.08.535","volume":"3","author":"MD Stubblefield","year":"2011","unstructured":"Stubblefield MD. Radiation fibrosis syndrome: neuromuscular and musculoskeletal complications in cancer survivors. Pm r. 2011;3(11):1041\u201354.","journal-title":"Pm r"},{"issue":"1","key":"2894_CR21","first-page":"9","volume":"5","author":"R Yahyapour","year":"2018","unstructured":"Yahyapour R, Amini P, Rezapour S, Cheki M, Rezaeyan A, Farhood B, et al. Radiation-induced inflammation and autoimmune diseases. Mil Med Res. 2018;5(1):9.","journal-title":"Mil Med Res"},{"key":"2894_CR22","doi-asserted-by":"crossref","unstructured":"Barrios-Anderson A, Radhakrishnan R, Yu E, Shimanovsky A. Paraspinal radiation recall myositis after gemcitabine for pancreatic adenocarcinoma. BMJ Case Rep. 2021;14(5).","DOI":"10.1136\/bcr-2020-240896"},{"issue":"10","key":"2894_CR23","first-page":"e250014","volume":"45","author":"A Azhideh","year":"2025","unstructured":"Azhideh A, Haseli S, Schaub SK, Amini B, Hosseini N, Mansoori B, et al. Musculoskelet Complications Radiation Therapy Immunotherapy Radiographics. 2025;45(10):e250014.","journal-title":"Musculoskelet Complications Radiation Therapy Immunotherapy Radiographics"},{"issue":"4","key":"2894_CR24","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ijrobp.2018.04.043","volume":"110","author":"JR Bellon","year":"2021","unstructured":"Bellon JR, Recht A. Radiation Therapy in a Patient With Dermatomyositis and Delayed Wound Healing. Int J Radiat Oncol Biol Phys. 2021;110(4):942.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2894_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13019-022-01860-4","volume":"17","author":"Y Lei","year":"2022","unstructured":"Lei Y, Liu C, Wan X, Yang Y, Yao Y, Luo L, et al. Polymyositis as a paraneoplastic syndrome of a patient with primary pulmonary lymphoepithelioma-like carcinoma: a case report and literature review. J Cardiothorac Surg. 2022;17(1):120.","journal-title":"J Cardiothorac Surg"},{"issue":"7\u20138","key":"2894_CR26","doi-asserted-by":"publisher","first-page":"103581","DOI":"10.1016\/j.autrev.2024.103581","volume":"23","author":"P Ruscitti","year":"2024","unstructured":"Ruscitti P, Allanore Y, Baldini C, Barilaro G, Bartoloni Bocci E, Bearzi P, et al. Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts\u2019 consensus. Autoimmun Rev. 2024;23(7\u20138):103581.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"2894_CR27","first-page":"1073","volume":"22","author":"I Zerdes","year":"2017","unstructured":"Zerdes I, Tolia M, Nikolaou M, Tsoukalas N, Velentza L, Hajiioannou J, et al. How can we effectively address the paraneoplastic dermatomyositis: Diagnosis, risk factors and treatment options. J buon. 2017;22(4):1073\u201380.","journal-title":"J buon"},{"issue":"3","key":"2894_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00256-014-1996-1","volume":"44","author":"JA Delavan","year":"2015","unstructured":"Delavan JA, Chino JP, Vinson EN. Gemcitabine-induced radiation recall myositis. Skeletal Radiol. 2015;44(3):451\u20135.","journal-title":"Skeletal Radiol"},{"issue":"4","key":"2894_CR29","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1177\/10781552221125869","volume":"29","author":"MP Varan","year":"2023","unstructured":"Varan MP, Turna H, \u00d6ner Din\u00e7ba\u015f F. Radiation recall myositis with pazopanib in a patient with soft tissue sarcoma. J Oncol Pharm Pract. 2023;29(4):980\u20135.","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"2894_CR30","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s13256-022-03664-5","volume":"16","author":"PY Cren","year":"2022","unstructured":"Cren PY, Penel N, Cordoba A, Decanter G, Gaboriau L, Ben Haj Amor M. Myositis ossificans circumscripta after surgery and radiotherapy and during sunitinib treatment: a case report. J Med Case Rep. 2022;16(1):454.","journal-title":"J Med Case Rep"},{"key":"2894_CR31","doi-asserted-by":"crossref","unstructured":"Maeng CH, Park JS, Lee SA, Kim DH, Yun DH, Yoo SD et al. Radiation recall phenomenon presenting as myositis triggered by carboplatin plus paclitaxel and related literature review. J Cancer Res Ther. 2014;10:1093-7.","DOI":"10.4103\/0973-1482.146090"},{"issue":"9","key":"2894_CR32","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S1474-4422(25)00233-9","volume":"24","author":"J Raaphorst","year":"2025","unstructured":"Raaphorst J, van der Kooi AJ, Mecoli CA, Weihl CC, Tas SW, Schmidt J, et al. Advances in the classification and management of idiopathic inflammatory myopathies. Lancet Neurol. 2025;24(9):776\u201388.","journal-title":"Lancet Neurol"},{"key":"2894_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12957-015-0534-5","volume":"13","author":"LP Dias","year":"2015","unstructured":"Dias LP, Faria AL, Scandiuzzi MM, Inhaia CL, Shida JY, Gebrim LH. A rare case of severe myositis as paraneoplastic syndrome on breast cancer. World J Surg Oncol. 2015;13:134.","journal-title":"World J Surg Oncol"},{"issue":"3","key":"2894_CR34","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s12253-019-00756-4","volume":"26","author":"C Andr\u00e1s","year":"2020","unstructured":"Andr\u00e1s C, Bodoki L, Nagy-Vincze M, Griger Z, Csiki E, Dank\u00f3 K. Retrospective Analysis of Cancer-Associated Myositis Patients over the Past 3 Decades in a Hungarian Myositis Cohort. Pathol Oncol Res. 2020;26(3):1749\u201355.","journal-title":"Pathol Oncol Res"},{"issue":"9","key":"2894_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1470-2045(03)01191-4","volume":"4","author":"HB Stone","year":"2003","unstructured":"Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol. 2003;4(9):529\u201336.","journal-title":"Lancet Oncol"},{"issue":"2","key":"2894_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.semradonc.2006.11.005","volume":"17","author":"HP Rodemann","year":"2007","unstructured":"Rodemann HP, Blaese MA. Responses of normal cells to ionizing radiation. Semin Radiat Oncol. 2007;17(2):81\u20138.","journal-title":"Semin Radiat Oncol"},{"issue":"7","key":"2894_CR37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nrc3958","volume":"15","author":"HE Barker","year":"2015","unstructured":"Barker HE, Paget JT, Khan AA, Harrington KJ. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015;15(7):409\u201325.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2894_CR38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.radonc.2004.08.021","volume":"73","author":"S Delanian","year":"2004","unstructured":"Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004;73(2):119\u201331.","journal-title":"Radiother Oncol"},{"issue":"2","key":"2894_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214(2):199\u2013210.","journal-title":"J Pathol"},{"issue":"1","key":"2894_CR40","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1186\/s12967-023-04554-0","volume":"21","author":"Z Yu","year":"2023","unstructured":"Yu Z, Xu C, Song B, Zhang S, Chen C, Li C. Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances. J Transl Med. 2023;21(1):708.","journal-title":"J Transl Med"},{"key":"2894_CR41","doi-asserted-by":"crossref","unstructured":"Kreuder L, Bissey PA, Yip KW, Liu FF. Exploring radiation-induced fibrosis: biological mechanisms and new frontiers in research and therapeutics. Int J Radiat Biol. 2025;1\u201316.","DOI":"10.1080\/09553002.2025.2540353"},{"issue":"4","key":"2894_CR42","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.semradonc.2017.04.001","volume":"27","author":"DE Citrin","year":"2017","unstructured":"Citrin DE, Mitchell JB. Mechanisms of Normal Tissue Injury From Irradiation. Semin Radiat Oncol. 2017;27(4):316\u201324.","journal-title":"Semin Radiat Oncol"},{"issue":"4","key":"2894_CR43","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/0360-3016(89)90074-6","volume":"17","author":"R Fleck","year":"1989","unstructured":"Fleck R, McNeese MD, Ellerbroek NA, Hunter TA, Holmes FA. Consequences of breast irradiation in patients with pre-existing collagen vascular diseases. Int J Radiat Oncol Biol Phys. 1989;17(4):829\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2894_CR44","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","volume":"41","author":"L Deng","year":"2014","unstructured":"Deng L, Liang H, Xu M, Yang X, Burnette B, Arina A, et al. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. Immunity. 2014;41(5):843\u201352.","journal-title":"Immunity"},{"key":"2894_CR45","doi-asserted-by":"publisher","first-page":"15618","DOI":"10.1038\/ncomms15618","volume":"8","author":"C Vanpouille-Box","year":"2017","unstructured":"Vanpouille-Box C, Alard A, Aryankalayil MJ, Sarfraz Y, Diamond JM, Schneider RJ, et al. DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity. Nat Commun. 2017;8:15618.","journal-title":"Nat Commun"},{"issue":"4","key":"2894_CR46","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jnci\/djs629","volume":"105","author":"SC Formenti","year":"2013","unstructured":"Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst. 2013;105(4):256\u201365.","journal-title":"J Natl Cancer Inst"},{"key":"2894_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fonc.2012.00153","volume":"2","author":"S Demaria","year":"2012","unstructured":"Demaria S, Formenti SC. Radiation as an immunological adjuvant: current evidence on dose and fractionation. Front Oncol. 2012;2:153.","journal-title":"Front Oncol"},{"issue":"1","key":"2894_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijrobp.2011.05.065","volume":"83","author":"D Lundstedt","year":"2012","unstructured":"Lundstedt D, Gustafsson M, Steineck G, Malmstr\u00f6m P, Alsadius D, Sundberg A, et al. Risk factors of developing long-lasting breast pain after breast cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2012;83(1):71\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"2894_CR49","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s00117-018-0412-6","volume":"58","author":"T Welzel","year":"2018","unstructured":"Welzel T, Tanner JM. [Imaging of side effects after radiation therapy]. Radiologe. 2018;58(8):754\u201361.","journal-title":"Radiologe"},{"key":"2894_CR50","doi-asserted-by":"publisher","first-page":"110591","DOI":"10.1016\/j.radonc.2024.110591","volume":"202","author":"F De Rose","year":"2025","unstructured":"De Rose F, Carmen De Santis M, Lucidi S, Ray Colciago R, Marino L, Cucciarelli F, et al. Dose constraints in breast cancer radiotherapy. A critical review. Radiother Oncol. 2025;202:110591.","journal-title":"Radiother Oncol"},{"issue":"5","key":"2894_CR51","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0360-3016(96)00426-9","volume":"36","author":"I Turesson","year":"1996","unstructured":"Turesson I, Nyman J, Holmberg E, Od\u00e9n A. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys. 1996;36(5):1065\u201375.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2894_CR52","doi-asserted-by":"publisher","first-page":"e429","DOI":"10.3747\/co.24.3696","volume":"24","author":"E Hendren","year":"2017","unstructured":"Hendren E, Vinik O, Faragalla H, Haq R. Breast cancer and dermatomyositis: a case study and literature review. Curr Oncol. 2017;24(5):e429\u201333.","journal-title":"Curr Oncol"},{"issue":"2","key":"2894_CR53","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1308\/rcsann.2016.0301","volume":"99","author":"N Merali","year":"2017","unstructured":"Merali N, Yousuff M, Pronisceva V, Poddar A. Paraneoplastic polymyositis presenting as a clinically occult breast cancer. Ann R Coll Surg Engl. 2017;99(2):e40\u20133.","journal-title":"Ann R Coll Surg Engl"},{"key":"2894_CR54","doi-asserted-by":"crossref","unstructured":"Dandasena T, Ingle V, Singhai A, Saigal S. Anti-SRP-positive necrotising myopathy concurrent with breast malignancy. BMJ Case Rep. 2023;16(12).","DOI":"10.1136\/bcr-2023-254702"},{"issue":"4","key":"2894_CR55","first-page":"165","volume":"34","author":"M Malini\u0107","year":"2025","unstructured":"Malini\u0107 M, Relji\u0107 V, Vukovi\u0107 J, Tanasilovi\u0107 S, \u017divanovi\u0107 D. Dermatomyositis in women: a 15-year retrospective analysis of clinical patterns, malignancy risk, and long-term outcomes at a tertiary center. Acta Dermatovenerol Alp Pannonica Adriat. 2025;34(4):165\u20139.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"11","key":"2894_CR56","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1002\/1097-0142(19930601)71:11<3744::AID-CNCR2820711144>3.0.CO;2-C","volume":"71","author":"JG Ross","year":"1993","unstructured":"Ross JG, Hussey DH, Mayr NA, Davis CS. Acute and late reactions to radiation therapy in patients with collagen vascular diseases. Cancer. 1993;71(11):3744\u201352.","journal-title":"Cancer"},{"issue":"7","key":"2894_CR57","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1200\/JCO.1997.15.7.2728","volume":"15","author":"MM Morris","year":"1997","unstructured":"Morris MM, Powell SN. Irradiation in the setting of collagen vascular disease: acute and late complications. J Clin Oncol. 1997;15(7):2728\u201335.","journal-title":"J Clin Oncol"},{"issue":"6","key":"2894_CR58","first-page":"480","volume":"7","author":"AM Chen","year":"2001","unstructured":"Chen AM, Obedian E, Haffty BG. Breast-conserving therapy in the setting of collagen vascular disease. Cancer J. 2001;7(6):480\u201391.","journal-title":"Cancer J"},{"issue":"3","key":"2894_CR59","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ijrobp.2021.01.047","volume":"110","author":"JM Purswani","year":"2021","unstructured":"Purswani JM, Oh C, Jaros B, Sandigursky S, Xiao J, Gerber NK. Breast Conservation in Women with Autoimmune Disease: The Role of Active Autoimmune Disease and Hypofractionation on Acute and Late Toxicity in a Case-Controlled Series. Int J Radiat Oncol Biol Phys. 2021;110(3):783\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2894_CR60","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/S1470-2045(15)00417-9","volume":"17","author":"N Giaj-Levra","year":"2016","unstructured":"Giaj-Levra N, Sciascia S, Fiorentino A, Fersino S, Mazzola R, Ricchetti F, et al. Radiotherapy in patients with connective tissue diseases. Lancet Oncol. 2016;17(3):e109\u201317.","journal-title":"Lancet Oncol"},{"issue":"6","key":"2894_CR61","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/00130404-200311000-00005","volume":"9","author":"C Phan","year":"2003","unstructured":"Phan C, Mindrum M, Silverman C, Paris K, Spanos W. Matched-control retrospective study of the acute and late complications in patients with collagen vascular diseases treated with radiation therapy. Cancer J. 2003;9(6):461\u20136.","journal-title":"Cancer J"},{"key":"2894_CR62","doi-asserted-by":"crossref","unstructured":"Selva-O\u2019Callaghan A, Trallero-Aragu\u00e1s E, Gil-Vila A, Matas-Garcia A, Edo C, Milisenda J et al. Treatment algorithms for inflammatory myopathies in adults: from guidelines to clinical practice. Curr Treatm Opt Rheumatol. 2025;11.","DOI":"10.1007\/s40674-025-00239-5"},{"issue":"4","key":"2894_CR63","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1093\/rheumatology\/keae470","volume":"64","author":"X Wang","year":"2025","unstructured":"Wang X, Albayda J, Paik JJ, Tiniakou E, Adler B, Mammen AL, et al. Evaluating CA-125 and PET\/CT for cancer detection in idiopathic inflammatory myopathies. Rheumatology (Oxford). 2025;64(4):2115\u201322.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"2894_CR64","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/MNM.0000000000000981","volume":"40","author":"PG Maliha","year":"2019","unstructured":"Maliha PG, Hudson M, Abikhzer G, Singerman J, Probst S. 18F-FDG PET\/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications. Nucl Med Commun. 2019;40(4):377\u201382.","journal-title":"Nucl Med Commun"},{"issue":"6","key":"2894_CR65","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1093\/rheumatology\/keaf116","volume":"64","author":"JJ Paik","year":"2025","unstructured":"Paik JJ, Werth VP, Chinoy H, Masri KR, Jambekar A, Hasan F, et al. Treatment guidelines for idiopathic inflammatory myopathies in adults: a comparative review. Rheumatology (Oxford). 2025;64(6):3288\u2013302.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-026-02894-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02894-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02894-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:05:30Z","timestamp":1791821130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-026-02894-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2894"],"URL":"https:\/\/doi.org\/10.1186\/s13014-026-02894-x","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"28 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors used ChatGPT exclusively for English language editing and to improve readability. All outputs were critically reviewed and edited by the authors, who take full responsibility for the final content of the article.","order":2,"name":"Ethics","label":"AI statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"138"}}